Back to search
FDAFDA · Food and drugs·Recall number D-0651-2022

Alprazolam C-IV 2 mg, 60-count bottles, Rx Only, Dist. By: Par Pharmaceutical Chestnut Ridge, NY 10977 Packaged and Distributed By: Direct Rx Dawsonville, GA 30534, NDC 72189-0058-60

Published March 16, 2022 · Recall initiated: March 4, 2022

Summary

FDA records drug Class II recall D-0651-2022, published March 16, 2022 and initiated March 4, 2022. Recalling firm: Direct Rx; Status: Terminated; Reported quantity: 8 bottles; Lot: Lot #: 07NO1901 Exp. 5/31/22. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

CGMP Deviations: The Recall is due to the potential cross-contamination at the contract manufacturer (Ultra Tab Laboratories Inc.)

What to do

Voluntary: Firm initiated · Letter

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Direct Rx
Distributor
FL, GA, LA
Lot
Lot #: 07NO1901 Exp. 5/31/22
Risk classification
Class II
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Alprazolam C-IV 2 mg, 60-count bottles, Rx Only, Dist. By: Par Pharmaceutical Chestnut Ridge, NY 10977 Packaged and Distributed By: Direct Rx Dawsonville, GA 30534, NDC 72189-0058-60 recalled?

Yes. FDA published recall D-0651-2022 on March 16, 2022. Reported hazard: CGMP Deviations: The Recall is due to the potential cross-contamination at the contract manufacturer (Ultra Tab Laboratories Inc.)

What should I do if I have this product?

Voluntary: Firm initiated · Letter